In 2022, the Swiss pharmaceutical industry transferred some CHF218 million ($243 million) to doctors, hospitals and other healthcare providers, according to the self-declaration of 65 pharmaceutical companies. Novartis topped the list with CHF31 million.
This content was published on
2 minutes
Keystone-SDA
Português
pt
Indústria farmacêutica suíça pagou CHF 218 milhões a prestadores de serviços de saúde
Since 2015, the industry has been reporting its payments to healthcare providers under its Code of Pharmaceutical Cooperation. Over eight years, the companies have paid a total of CHF1.4 billion to the medical profession and hospitals.
Journalists from the Ringier Axel Springer publishing house evaluated the figures and published them on Thursday. The pharmaceutical association Scienceindustries confirmed the figures to the Keystone-SDA news agency.
Roche came in second place behind Novartis, with CHF21.9 million paid out, followed by the American group Pfizer with CHF20 million.
According to Scienceindustries, the payments are governed by law and authorised for research, continuing education, consultancy and other services. The industry lists the recipients individually and by name.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Swiss Politics
In Switzerland, New Year brings ‘burka ban’ and pension hikes
This content was published on
Switzerland is one of the frontrunners at investing in technology start-ups, according to a study by the European Patent Office.
Geneva university challenges ‘hot Jupiter’ planetary theories
This content was published on
Research led by the University of Geneva challenges current theories about the formation of 'hot Jupiter' planetary systems.
Bankrupt debtors to get second chance in Switzerland
This content was published on
Over-indebted people in Switzerland will be offered a new chance to wipe the slate clean with new procedures to restructure debt.
Swiss drone flights suspended after India incident
This content was published on
Swiss army suspends ADS 15 reconnaissance drone flights following an incident involving a drone of the same type in India.
Zurich traffic signs get gender diversification makeover
This content was published on
The little men depicted on Zurich street signs are to be joined by women, pregnant women, lesbian couples or senior citizens with walking sticks.
This content was published on
A Swiss study suggests that the Gulf Stream hasn’t weakened yet, but it’s too early to sound the all-clear on future climate change.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.